S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
FB   217.49 (-0.14%)
MSFT   187.28 (+0.03%)
GOOGL   1,524.87 (+0.36%)
AMZN   2,170.22 (+0.67%)
NVDA   314.70 (+6.11%)
BABA   222.14 (+0.73%)
GE   12.61 (-1.10%)
AMD   58.90 (+3.53%)
T   38.44 (+0.47%)
ACB   1.71 (+4.27%)
F   8.00 (-0.74%)
NFLX   386.19 (-0.41%)
PRI   135.69 (+0.05%)
BAC   34.72 (+1.31%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
FB   217.49 (-0.14%)
MSFT   187.28 (+0.03%)
GOOGL   1,524.87 (+0.36%)
AMZN   2,170.22 (+0.67%)
NVDA   314.70 (+6.11%)
BABA   222.14 (+0.73%)
GE   12.61 (-1.10%)
AMD   58.90 (+3.53%)
T   38.44 (+0.47%)
ACB   1.71 (+4.27%)
F   8.00 (-0.74%)
NFLX   386.19 (-0.41%)
PRI   135.69 (+0.05%)
BAC   34.72 (+1.31%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
FB   217.49 (-0.14%)
MSFT   187.28 (+0.03%)
GOOGL   1,524.87 (+0.36%)
AMZN   2,170.22 (+0.67%)
NVDA   314.70 (+6.11%)
BABA   222.14 (+0.73%)
GE   12.61 (-1.10%)
AMD   58.90 (+3.53%)
T   38.44 (+0.47%)
ACB   1.71 (+4.27%)
F   8.00 (-0.74%)
NFLX   386.19 (-0.41%)
PRI   135.69 (+0.05%)
BAC   34.72 (+1.31%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
FB   217.49 (-0.14%)
MSFT   187.28 (+0.03%)
GOOGL   1,524.87 (+0.36%)
AMZN   2,170.22 (+0.67%)
NVDA   314.70 (+6.11%)
BABA   222.14 (+0.73%)
GE   12.61 (-1.10%)
AMD   58.90 (+3.53%)
T   38.44 (+0.47%)
ACB   1.71 (+4.27%)
F   8.00 (-0.74%)
NFLX   386.19 (-0.41%)
PRI   135.69 (+0.05%)
BAC   34.72 (+1.31%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
Log in

NASDAQ:IRMD - Iradimed Stock Price, Forecast & News

$26.42
+0.46 (+1.77 %)
(As of 02/19/2020 04:00 PM ET)
Today's Range
$25.79
Now: $26.42
$26.71
50-Day Range
$23.35
MA: $25.59
$26.88
52-Week Range
$16.68
Now: $26.42
$29.80
Volume40,104 shs
Average Volume52,064 shs
Market Capitalization$303.43 million
P/E Ratio33.87
Dividend YieldN/A
Beta1.65
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:IRMD
CUSIPN/A
Phone407-677-8022

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$38.52 million
Cash Flow$0.58 per share
Book Value$3.84 per share

Profitability

Net Income$9.63 million

Miscellaneous

Employees95
Market Cap$303.43 million
Next Earnings Date5/5/2020 (Estimated)
OptionableNot Optionable

Receive IRMD News and Ratings via Email

Sign-up to receive the latest news and ratings for IRMD and its competitors with MarketBeat's FREE daily newsletter.


Iradimed (NASDAQ:IRMD) Frequently Asked Questions

What is Iradimed's stock symbol?

Iradimed trades on the NASDAQ under the ticker symbol "IRMD."

How were Iradimed's earnings last quarter?

Iradimed Corp (NASDAQ:IRMD) issued its quarterly earnings data on Thursday, February, 6th. The medical equipment provider reported $0.30 earnings per share for the quarter, beating analysts' consensus estimates of $0.20 by $0.10. The medical equipment provider had revenue of $10.89 million for the quarter, compared to analysts' expectations of $10.96 million. Iradimed had a net margin of 25.01% and a return on equity of 18.95%. View Iradimed's Earnings History.

When is Iradimed's next earnings date?

Iradimed is scheduled to release their next quarterly earnings announcement on Tuesday, May 5th 2020. View Earnings Estimates for Iradimed.

What guidance has Iradimed issued on next quarter's earnings?

Iradimed updated its FY 2020 Pre-Market earnings guidance on Thursday, February, 6th. The company provided EPS guidance of 0.84-0.92 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.92. The company issued revenue guidance of $46.3-47.1 million, compared to the consensus revenue estimate of $46.96 million.

Has Iradimed been receiving favorable news coverage?

Media coverage about IRMD stock has been trending somewhat negative on Wednesday, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Iradimed earned a coverage optimism score of -1.4 on InfoTrie's scale. They also gave press coverage about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near future. View News Stories for Iradimed.

Are investors shorting Iradimed?

Iradimed saw a increase in short interest in the month of January. As of January 31st, there was short interest totalling 500,800 shares, an increase of 8.7% from the January 15th total of 460,900 shares. Based on an average daily volume of 65,300 shares, the days-to-cover ratio is currently 7.7 days. Currently, 9.3% of the shares of the company are short sold. View Iradimed's Current Options Chain.

Who are some of Iradimed's key competitors?

What other stocks do shareholders of Iradimed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Iradimed investors own include NVIDIA (NVDA), Gilead Sciences (GILD), Micron Technology (MU), Paypal (PYPL), Alphabet (GOOG), Mastercard (MA), Palo Alto Networks (PANW), Verizon Communications (VZ), Align Technology (ALGN) and IntriCon (IIN).

Who are Iradimed's key executives?

Iradimed's management team includes the folowing people:
  • Mr. Roger E. Susi, Founder, Chairman, CEO & Pres (Age 66)
  • Mr. Christopher K. Scott, CFO & Sec. (Age 49)
  • Mr. John McCreery, Chief Operating Officer (Age 64)
  • Mr. Brent Johnson, Exec. VP of Worldwide Sales & Marketing (Age 60)
  • Mr. Louis Waldman, Controller (Age 64)

Who are Iradimed's major shareholders?

Iradimed's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Renaissance Technologies LLC (4.65%), Russell Investments Group Ltd. (2.39%), Cadence Capital Management LLC (0.93%), Parkman Healthcare Partners LLC (0.81%), Marshall Wace LLP (0.58%) and State Street Corp (0.57%). Company insiders that own Iradimed stock include Anthony Vuoto, Brent Johnson, Christopher K Scott, Francis X Casey, John K Mccreery, Louis S Waldman, Monty K Allen, Roger E Susi and Steven M Nardi. View Institutional Ownership Trends for Iradimed.

Which institutional investors are selling Iradimed stock?

IRMD stock was sold by a variety of institutional investors in the last quarter, including Marshall Wace LLP, AQR Capital Management LLC, Bank of America Corp DE, Cadence Capital Management LLC, Chicago Equity Partners LLC, Navellier & Associates Inc and Fiera Capital Corp. Company insiders that have sold Iradimed company stock in the last year include Anthony Vuoto, Brent Johnson, Louis S Waldman, Monty K Allen and Steven M Nardi. View Insider Buying and Selling for Iradimed.

Which institutional investors are buying Iradimed stock?

IRMD stock was purchased by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Renaissance Technologies LLC, Parkman Healthcare Partners LLC, Rice Hall James & Associates LLC, Bank of Montreal Can, Oxford Asset Management LLP, Algert Global LLC and Acadian Asset Management LLC. View Insider Buying and Selling for Iradimed.

How do I buy shares of Iradimed?

Shares of IRMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Iradimed's stock price today?

One share of IRMD stock can currently be purchased for approximately $26.42.

How big of a company is Iradimed?

Iradimed has a market capitalization of $303.43 million and generates $38.52 million in revenue each year. The medical equipment provider earns $9.63 million in net income (profit) each year or $0.78 on an earnings per share basis. Iradimed employs 95 workers across the globe.View Additional Information About Iradimed.

What is Iradimed's official website?

The official website for Iradimed is http://www.iradimed.com/.

How can I contact Iradimed?

Iradimed's mailing address is 1025 Willa Springs Dr., Winter Springs FL, 32708. The medical equipment provider can be reached via phone at 407-677-8022 or via email at [email protected]


MarketBeat Community Rating for Iradimed (NASDAQ IRMD)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  220 (Vote Outperform)
Underperform Votes:  230 (Vote Underperform)
Total Votes:  450
MarketBeat's community ratings are surveys of what our community members think about Iradimed and other stocks. Vote "Outperform" if you believe IRMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IRMD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/19/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel